Meningioma: Risk Factors and Quality of Life

脑膜瘤:危险因素和生活质量

基本信息

  • 批准号:
    7825342
  • 负责人:
  • 金额:
    $ 9.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-26 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): No large-scale study within the United States has examined any aspect of the epidemiology of intracranial meningiomas, a lesion which accounts for up to 25% of all primary intracranial neoplasms. We propose to conduct a population-based case/control study of meningioma within the states of Connecticut, Massachusetts, North Carolina, and Texas as well as the San Francisco Bay area under the mechanism of an integrated R01 (Note that identical applications are submitted for all five sites). Cases will be selected using rapid case ascertainment and will include all male; and female individuals diagnosed with a histologically confirmed intra-cranial meningioma between the ages of 20 and 79 years from 7/1/2006 through 6/30/2010 in the above listed regions. Control subjects will be identified via random-digit dial methods and matched to the cases by sex, ethnicity, geographic location, and five-year age category. Study subjects will be administered a telephone questionnaire to collect information on the two primary categories of risk, exposure to ionizing radiation and hormones as well as additional risk factors such as family history of meningioma and other tumors, cell-phone utilization, and head trauma as well as questions on outcome and quality of life. Parraffin-embedded tumor tissue blocks will be obtained for case subjects to allow for 1) a uniform histological review, and 2) immunohistochemical testing for estrogen, progesterone, androgen and MIB-1 receptors. Blood or buccal specimens will be collected from all study subjects for testing of DNA polymorphisms in DNA repair and cell cycle genes. This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma.
描述(申请人提供):在美国国内还没有大规模研究对颅内脑膜瘤的流行病学进行任何方面的研究,脑膜瘤占所有原发颅内肿瘤的25%。我们建议在康涅狄格州、马萨诸塞州、北卡罗来纳州、德克萨斯州以及旧金山湾区的综合R01机制下进行一项基于人群的脑膜瘤病例/对照研究(请注意,所有五个地点都提交了相同的申请)。将使用快速病例确定方法选择病例,将包括上述地区所有男性;以及在2006年7月1日至2010年6月30日期间被诊断患有组织学确诊的20岁至79岁颅内脑膜瘤的女性个人。对照受试者将通过随机数字拨号方法识别,并按性别、种族、地理位置和五岁年龄类别与病例匹配。研究对象将接受电话问卷调查,以收集有关两种主要风险类别的信息,即暴露在电离辐射和激素中,以及其他风险因素,如脑膜瘤和其他肿瘤的家族史、手机使用情况、头部创伤以及有关结局和生活质量的问题。对于病例受试者,将获得石蜡包埋的肿瘤组织块,以允许1)统一的组织学检查,以及2)雌激素、孕激素、雄激素和MIB-1受体的免疫组织化学测试。血液或口腔样本将从所有研究对象中收集,用于检测DNA修复和细胞周期基因的DNA多态。这项研究是首次集中研究脑膜瘤的环境和遗传风险因素。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dental x-rays and risk of meningioma.
  • DOI:
    10.1002/cncr.26625
  • 发表时间:
    2012-09-15
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Claus EB;Calvocoressi L;Bondy ML;Schildkraut JM;Wiemels JL;Wrensch M
  • 通讯作者:
    Wrensch M
Assessment of autoantibodies to meningioma in a population-based study.
在基于人群的研究中评估脑膜瘤自身抗体。
  • DOI:
    10.1093/aje/kws221
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Wiemels,JosephL;Bracci,PaigeM;Wrensch,Margaret;Schildkraut,Joellen;Bondy,Melissa;Pfefferle,Jon;Zhou,Mi;Sison,Jennette;Calvocoressi,Lisa;Claus,ElizabethB
  • 通讯作者:
    Claus,ElizabethB
Dental x-rays and risk of meningioma: response to Drs. Calnon, Jorgensen, and White.
牙科 X 光检查和脑膜瘤风险:对 Drs 的反应。
  • DOI:
    10.1002/cncr.27708
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Claus,ElizabethB;Wiemels,Joseph;Wrensch,Margaret
  • 通讯作者:
    Wrensch,Margaret
Quality of life after surgery for intracranial meningioma.
  • DOI:
    10.1002/cncr.30975
  • 发表时间:
    2018-01-01
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Benz LS;Wrensch MR;Schildkraut JM;Bondy ML;Warren JL;Wiemels JL;Claus EB
  • 通讯作者:
    Claus EB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DORA ILYASOVA其他文献

DORA ILYASOVA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DORA ILYASOVA', 18)}}的其他基金

Urinary F2-isoprostanes as a new biomarker for the risk of type 2 diabetes
尿 F2-异前列腺素作为 2 型糖尿病风险的新生物标志物
  • 批准号:
    7761765
  • 财政年份:
    2009
  • 资助金额:
    $ 9.99万
  • 项目类别:
Urinary F2-isoprostanes as a new biomarker for the risk of type 2 diabetes
尿 F2-异前列腺素作为 2 型糖尿病风险的新生物标志物
  • 批准号:
    7582571
  • 财政年份:
    2009
  • 资助金额:
    $ 9.99万
  • 项目类别:
Urinary F2-Isoprostanes As A New Biomarker For The Risk Of Type 2 Diabetes
尿液 F2-异前列烷作为 2 型糖尿病风险的新生物标志物
  • 批准号:
    8018105
  • 财政年份:
    2009
  • 资助金额:
    $ 9.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了